Mario Gabelli acquired 11k Neogenomics shares worth $88.7k. That's 0.00% of their equity portfolio (977th largest holding). The first Neogenomics trade was made in Q2 2014. Since then Mario Gabelli bought shares eleven more times and sold shares on 21 occasions. The investor's estimated purchase price is $88.7k, resulting in a loss of 0.0%.